Is there really a specific graft-versus-leukaemia effect?

被引:13
作者
Gale, R. P. [1 ]
Fuchs, E. J. [2 ]
机构
[1] Imperial Coll London, Div Expt Med, Haematol Res Ctr, Dept Med, London SW7 2AZ, England
[2] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Hematol Malignancies, Dept Med, Baltimore, MD USA
关键词
ACUTE MYELOID-LEUKEMIA; HOST-DISEASE; CELL TRANSPLANTATION; CLINICAL-TRIALS; REMISSION; OUTCOMES; THERAPY; BLOOD; RISK;
D O I
10.1038/bmt.2016.183
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
[No abstract available]
引用
收藏
页码:1413 / 1415
页数:3
相关论文
共 16 条
[1]  
Bacigalupo Andrea, 2016, Adv Hematol, V2016, P7802967, DOI 10.1155/2016/7802967
[2]   Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia [J].
Ciurea, Stefan O. ;
Zhang, Mei-Jie ;
Bacigalupo, Andrea A. ;
Bashey, Asad ;
Appelbaum, Frederick R. ;
Aljitawi, Omar S. ;
Armand, Philippe ;
Antin, Joseph H. ;
Chen, Junfang ;
Devine, Steven M. ;
Fowler, Daniel H. ;
Luznik, Leo ;
Nakamura, Ryotaro ;
O'Donnell, Paul V. ;
Perales, Miguel-Angel ;
Pingali, Sai Ravi ;
Porter, David L. ;
Riches, Marcie R. ;
Ringden, Olle T. H. ;
Rocha, Vanderson ;
Vij, Ravi ;
Weisdorf, Daniel J. ;
Champlin, Richard E. ;
Horowitz, Mary M. ;
Fuchs, Ephraim J. ;
Eapen, Mary .
BLOOD, 2015, 126 (08) :1033-1040
[3]   Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell-Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303 [J].
Devine, Steven M. ;
Carter, Shelly ;
Soiffer, Robert J. ;
Pasquini, Marcelo C. ;
Hari, Parameswaran N. ;
Stein, Anthony ;
Lazarus, Hillard M. ;
Linker, Charles ;
Stadtmauer, Edward A. ;
Alyea, Edwin P., III ;
Keever-Taylor, Carolyn A. ;
O'Reilly, Richard J. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (09) :1343-1351
[4]   Commentary: does immune suppression increase risk of developing acute myeloid leukemia? [J].
Gale, R. P. ;
Opelz, G. .
LEUKEMIA, 2012, 26 (03) :422-423
[5]  
Gosh N, J CLIN ONCOL, DOI [10.1200/JCO.2015.66.3476)., DOI 10.1200/JCO.2015.66.3476]
[6]  
HOROWITZ MM, 1990, BLOOD, V75, P555
[7]  
Kanakry CG, 2016, NAT REV CLIN ONCOL, V13, P10, DOI [10.1038/nrclinonc.2015.234, 10.1038/nrclinonc.2015.128]
[8]   Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies [J].
Kindwall-Keller, T. L. ;
Hegerfeldt, Y. ;
Meyerson, H. J. ;
Margevicius, S. ;
Fu, P. ;
van Heeckeren, W. ;
Lazarus, H. M. ;
Cooper, B. W. ;
Gerson, S. L. ;
Barr, P. ;
Tse, W. W. ;
Curtis, C. ;
Fanning, L. R. ;
Creger, R. J. ;
Carlson-Barko, J. M. ;
Laughlin, M. J. .
BONE MARROW TRANSPLANTATION, 2012, 47 (07) :924-933
[9]   Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras [J].
Luznik, L ;
Slansky, JE ;
Jalla, S ;
Borrello, I ;
Levitsky, HI ;
Pardoll, DM ;
Fuchs, EJ .
BLOOD, 2003, 101 (04) :1645-1652
[10]  
National Research Council, 1990, HLTH EFF EXP LOW LEV